
Věra Franková
Czech Republic
Věra Franková obtained her PhD in molecular biology and genetics from the Faculty of Natural Sciences at Charles University in 2002, following three years of research at the Max Planck Institute for Biology in Tübingen, Germany. She then focused on the psychosocial and ethical aspects of genetic testing, and in 2009 she defended her PhD thesis in medical ethics at the First Faculty of Medicine, Charles University, Prague (FFM CUNI). Since 2010, she has worked at the Institute for Medical Humanities (FFM CUNI), lecturing on bioethics. Věra also works as a medical ethics consultant at the Department of Paediatrics and Inherited Metabolic Disorders at the General University Hospital in Prague, as well as being an expert in bioethics at the Bank of Biological Material (FFM CUNI). She has also collaborated on international and national research projects as a researcher, e.g. Solve-RD (solve-rd.eu) and ACTG (www.acgt.cz/en/), and as an independent ethics advisor, e.g. the ERC 2022 ADG Oncolipid project. She is also involved in the national implementation of the European Open Science Cloud initiative in the area of sensitive data governance. Her main professional interests are ethical, legal and social implications (ELSI) of genomics, newborn screening and biobanking.

Věra Franková
Germany
Věra Franková obtained her PhD in molecular biology and genetics from the Faculty of Natural Sciences at Charles University in 2002, following three years of research at the Max Planck Institute for Biology in Tübingen, Germany. She then focused on the psychosocial and ethical aspects of genetic testing, and in 2009 she defended her PhD thesis in medical ethics at the First Faculty of Medicine, Charles University, Prague (FFM CUNI). Since 2010, she has worked at the Institute for Medical Humanities (FFM CUNI), lecturing on bioethics. Věra also works as a medical ethics consultant at the Department of Paediatrics and Inherited Metabolic Disorders at the General University Hospital in Prague, as well as being an expert in bioethics at the Bank of Biological Material (FFM CUNI). She has also collaborated on international and national research projects as a researcher, e.g. Solve-RD (solve-rd.eu) and ACTG (www.acgt.cz/en/), and as an independent ethics advisor, e.g. the ERC 2022 ADG Oncolipid project. She is also involved in the national implementation of the European Open Science Cloud initiative in the area of sensitive data governance. Her main professional interests are ethical, legal and social implications (ELSI) of genomics, newborn screening and biobanking.

































